Pathologic improvement after high-dose melphalan and autologous stem cell transplantation for primary systemic amyloidosis

NDT Plus

Volumn 1, Issue 6, 2008, Pages 414-416

  Hoshino, Junichi ^a,b   Ubara, Yoshifumi ^a   Ohashi, Kenichi ^a   Takemoto, Fumi ^a   Takaichi, Kenmei ^a  

^a TORANOMON HOSPITAL   (Japan)

^b NONE   (Japan)

Author keywords

AL amyloidosis; Autologous stem cell transplantation; High dose melphalan; Pathologic improvement

Indexed keywords

ALBUMIN; AMYLOID P COMPONENT; DEXAMETHASONE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; VINCRISTINE;

ADULT; ALBUMIN BLOOD LEVEL; AMYLOIDOSIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CASE REPORT; COMBINATION CHEMOTHERAPY; DISEASE COURSE; DRUG MEGADOSE; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; MALE; MULTIPLE CYCLE TREATMENT; NEPHRITIS; PRIORITY JOURNAL; PROTEINURIA; REMISSION; STEM CELL MOBILIZATION; STOMACH BIOPSY; TREATMENT RESPONSE;

EID: 56749182824     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfn144     Document Type: Article

References (5)

1. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995; 32: 45-59
2. Dubrey SW, Cha K, Anderson J et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 1998; 91: 141-157
3. Dispenzieri A, Kyle RA, Lacy MQ et al. Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study. Blood 2004; 103: 3960-3963
4. Skinner M, Sanchorawala V, Seldin DC et al. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med 2004; 140: 85-93
5. Gertz MA, Comenzo R, Falk RH et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol 2005; 79: 319-328